Host: Leslie P. Lundt, MD
Guest: Jorge Herrera, MD
The future of hepatitis C treatment looks bright -- most likely with the new oral, protease and polymerase inhibitors currently in development. Although these agents represent an exciting phase in the development of effective hepatitis C therapy, they are still a few years away from being recommended for routine clinical use. What can we look forward to? Expert hepatologist Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the latest research in Hepatitis C treatments.
